Skip to main content
. 2021 Dec 7;12(2):12107–12122. doi: 10.1080/21655979.2021.2003941

Figure 7.

Figure 7.

LINC00857 knockdown inhibits CRC tumorigenesis in vivo. HCT116 cells stably expressing sh-NC and sh-LIN00857 were injected into nude mice (n = 6 each), tumor size was monitored every 7 days. (a) sh-LIN00857 tumor growth was markedly inhibited as compared to sh-NC group. (b) The weight of tumors in sh-LIN00857 group was significantly lower as compared to sh-NC group. **P < 0.01, ***P < 0.001